Company intelligence / Profile preview

x-OvO

United Kingdom

Ownership: Private
Development stage: Other

Overview

x-OvO develops and commercializes comprehensive diagnostic tools for poultry disease management, leveraging its proprietary MTP platform to improve animal health, welfare, and production efficiency. The platform enables real-time, on-site pathogen detection and facilitates data-driven decisions for vaccination, nutrition, and biosecurity. In partnership with Alveo Technologies, x-OvO is launching a highly sensitive, multiplex molecular test for avian influenza, allowing rapid, field-based diagnosis and outbreak mapping to support global food security.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic toolMolecular diagnostic assay
Industry: Veterinary

Partnerships

Alveo TechnologiesRoyal GDPharmsure International Ltd

Beyond the preview

Go deeper on x-OvO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on x-OvO.

Explore the full profile